Extracorporeal liver support.
作者信息
Stange Jan
机构信息
Department of Internal Medicine, University of Rostock, Rostock, Germany.
出版信息
Organogenesis. 2011 Jan-Mar;7(1):64-73. doi: 10.4161/org.7.1.14069. Epub 2011 Jan 1.
Abstract
摘要
相似文献
1
Extracorporeal liver support.体外肝脏支持
Organogenesis. 2011 Jan-Mar;7(1):64-73. doi: 10.4161/org.7.1.14069. Epub 2011 Jan 1.
2
MARS: a new treatment for hepatorenal failure. Molecular adsorbent and recirculating system.
Gastroenterology. 2000 Dec;119(6):1799-800. doi: 10.1016/s0016-5085(00)70033-3.
3
Artificial liver support at present and in the future.当前及未来的人工肝支持
J Artif Organs. 2006;9(1):17-28. doi: 10.1007/s10047-005-0320-1.
4
[Model selection and curative effect judgment criteria for artificial liver in the treatment of liver failure].
Zhonghua Gan Zang Bing Za Zhi. 2022 Feb 20;30(2):127-130. doi: 10.3760/cma.j.cn501113-20220108-00008.
5
Clearing of toxic substances: are there differences between the available liver support devices?清除体内毒素：现有的肝脏支持设备之间有区别吗？
Liver Int. 2011 Sep;31 Suppl 3:5-8. doi: 10.1111/j.1478-3231.2011.02588.x.
6
Artificial hepatic support. Where are we now?
Blood Purif. 2001;19(1):1-3. doi: 10.1159/000014469.
7
[Liver failure].
Nihon Rinsho. 2004 May;62 Suppl 5:545-9.
8
Successful MARS treatment in severe cholestatic patients with acute on chronic liver failure.
Artif Organs. 2003 Jun;27(6):565-9. doi: 10.1046/j.1525-1594.2003.07138.x.
9
[Coping with shortage of plasma and albumin: a strategy for artificial liver].
Zhonghua Gan Zang Bing Za Zhi. 2009 May;17(5):330-1.
10
[Apheresis treatment for fulminant hepatitis].
Nihon Rinsho. 2004 May;62 Suppl 5:462-6.
引用本文的文献
1
Extracorporeal organ support and the kidney.体外器官支持与肾脏
Front Nephrol. 2022 Aug 5;2:924363. doi: 10.3389/fneph.2022.924363. eCollection 2022.
2
Extracorporeal liver support techniques: a comparison.体外肝脏支持技术：比较。
J Artif Organs. 2024 Sep;27(3):261-268. doi: 10.1007/s10047-023-01409-9. Epub 2023 Jun 19.
3
Aggregate Removal Nanofiltration of Human Serum Albumin Solution Using Nanocellulose-Based Filter Paper.使用基于纳米纤维素的滤纸对人血清白蛋白溶液进行聚集体去除纳滤
Biomedicines. 2020 Jul 13;8(7):209. doi: 10.3390/biomedicines8070209.
4
Extracorporeal liver support: trending epidemiology and mortality - a nationwide database analysis 2007-2015.体外肝脏支持：趋势流行病学和死亡率 - 2007-2015 年全国数据库分析。
BMC Gastroenterol. 2019 Sep 3;19(1):160. doi: 10.1186/s12876-019-1077-y.
5
Effects of therapeutic plasma exchange on liver function test and coagulation parameters in acute liver failure patients.治疗性血浆置换对急性肝衰竭患者肝功能检查及凝血参数的影响。
Hematol Transfus Cell Ther. 2020 Apr-Jun;42(2):125-128. doi: 10.1016/j.htct.2019.05.003. Epub 2019 Jul 23.
6
Novel use of Cytosorb™ haemadsorption to provide biochemical control in liver impairment.Cytosorb™血液吸附在肝损伤中实现生化控制的新应用。
J Intensive Care Soc. 2019 May;20(2):174-181. doi: 10.1177/1751143718772789. Epub 2018 May 28.
7
CAAP48, a New Sepsis Biomarker, Induces Hepatic Dysfunction in an Liver-on-Chip Model.CAAP48，一种新的败血症生物标志物，在肝芯片模型中诱导肝损伤。
Front Immunol. 2019 Feb 25;10:273. doi: 10.3389/fimmu.2019.00273. eCollection 2019.
8
Removal of stabilizers from human serum albumin by adsorbents and dialysis used in blood purification.通过血液净化中使用的吸附剂和透析从人血清白蛋白中去除稳定剂。
PLoS One. 2018 Jan 24;13(1):e0191741. doi: 10.1371/journal.pone.0191741. eCollection 2018.
9
Alleviating liver failure conditions using an integrated hybrid cryogel based cellular bioreactor as a bioartificial liver support.使用基于集成混合水凝胶的细胞生物反应器缓解肝功能衰竭。
Sci Rep. 2017 Jan 12;7:40323. doi: 10.1038/srep40323.
本文引用的文献
1
Improvement of impaired albumin binding capacity in acute-on-chronic liver failure by albumin dialysis.通过白蛋白透析改善慢性肝衰竭急性发作时受损的白蛋白结合能力。
Liver Transpl. 2008 Sep;14(9):1333-9. doi: 10.1002/lt.21504.
2
Thermodynamic considerations in solid adsorption of bound solutes for patient support in liver failure.用于肝功能衰竭患者支持的结合溶质固体吸附中的热力学考量
Artif Organs. 2008 Jul;32(7):499-508. doi: 10.1111/j.1525-1594.2008.00581.x.
3
The effect of molecular adsorbent recirculating system treatment on survival, native liver recovery, and need for liver transplantation in acute liver failure patients.分子吸附循环系统治疗对急性肝衰竭患者生存率、自体肝恢复及肝移植需求的影响。
Transpl Int. 2008 Sep;21(9):857-66. doi: 10.1111/j.1432-2277.2008.00698.x. Epub 2008 May 29.
4
Effect of Prometheus liver assist system on systemic hemodynamics in patients with cirrhosis: a randomized controlled study.普罗米修斯肝脏辅助系统对肝硬化患者全身血流动力学的影响：一项随机对照研究。
World J Gastroenterol. 2008 Apr 7;14(13):2065-71. doi: 10.3748/wjg.14.2065.
5
Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis.晚期肝硬化肝性脑病患者体外白蛋白透析的随机对照研究
Hepatology. 2007 Dec;46(6):1853-62. doi: 10.1002/hep.21930.
6
Pediatric ventricular assist devices.小儿心室辅助装置
Pediatr Cardiol. 2007 Mar-Apr;28(2):149-55. doi: 10.1007/s00246-006-1453-6. Epub 2007 Jan 29.
7
A novel plasma filtration therapy for hepatic failure: preclinical studies.
Ther Apher Dial. 2006 Apr;10(2):138-44. doi: 10.1111/j.1744-9987.2006.00355.x.
8
Molecular absorbent recirculating system for the treatment of acute liver failure in surgical patients.用于治疗外科手术患者急性肝衰竭的分子吸附循环系统。
J Gastrointest Surg. 2005 Nov;9(8):1155-61; discussion 1161-2. doi: 10.1016/j.gassur.2005.07.026.
9
Is alcoholic hepatitis an indication for transplantation? Current management and outcomes.酒精性肝炎是移植的指征吗？当前的管理与结果。
Liver Transpl. 2005 Nov(11 Suppl 2):S21-4. doi: 10.1002/lt.20601.
10
Binding of bilirubin and bromosulphthalein to albumin: implications for understanding the pathophysiology of liver failure and its management.胆红素和溴磺酞钠与白蛋白的结合：对理解肝衰竭病理生理学及其治疗的意义。
Liver Transpl. 2004 Dec;10(12):1531-8. doi: 10.1002/lt.20323.
Zotero 插件